Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPD - Eosinophil-guided Reduction of Inhaled Corticosteroids (COPERNICOS)
2022-501035-16-01Phase 4Completed
- Sponsor
- Gentofte Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Azithromycin arm with Placebo arm (2 arms). Primary endpoint: Number of hospitalization-requiring exacerbations and/or death within 365 days. Started Aug 2022; status: completed.
02
Drugs
azithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2022-501035-16-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501035-16-01.